Bioli

Bioli is a Danish skincare company based in Søborg, near Copenhagen, that builds its products around bioactive enzyme technology. Founded in 2021, it positions lab-cultivated, microorganism-derived ingredients as a third path between conventional synthetic skincare and formulas extracted from plants [7]. The company frames its work around a single trade-off it repeats often: high impact on the skin, low impact on the environment.

The brand remains active and founder-led. Product launches through 2025, editorial interviews, and a regularly updated journal into mid-2026 all point to an operating business rather than a dormant label.

Bioli was created by Nina Wiberg Rosenquist, who had spent her earlier career at the Danish enzyme company Novozymes, later part of Novonesis [6]. According to an interview with the French retailer The Care, she started the company in 2021 after developing skin problems for the first time as she approached her thirties [7]. She has described that moment as the trigger for building something both sustainable and science-based, saying she felt she had the knowledge, and therefore the responsibility, to share what she had learned.

That enzyme-industry background runs through the whole brand. Rather than sourcing actives from farmed plants, Bioli works with microorganisms such as yeast, bacteria and fungi cultivated in the lab, an approach the company says needs less water, energy and land than agricultural cultivation.

Bioli's stated mission is to improve skin health while minimizing environmental impact through milder but still effective skincare [2]. The company organizes its identity around three ideas: biotechnology, biodegradable packaging, and "bioconscious", a coined term it explains as listening to your body while living a conscious life [7]. Its tagline sums the same thinking up as "100% bioactive, biodegradable, and bioconscious skincare" [1].

The positioning leans heavily on gentleness. Products are described as fragrance-free, allergy-certified and suitable for sensitive, acne-prone or reactive skin, with the enzyme actives presented as lower-irritation alternatives to more familiar ingredients such as exfoliating acids.

The line is compact and centers on a few core items: a Moisturizing and Protecting Day Cream, a Strengthening Serum, and a Clarifying Cleanser and Exfoliator, sold both directly and as bundles. The formulas are built on two enzyme systems the company brands as BioProtect, an enzyme-based antioxidant it says protects against free radicals and reduces redness, and BioRefine, a two-in-one enzyme technology meant to cleanse and, left on longer, gently exfoliate [3]. The specific enzymes named include superoxide dismutase, protease and lipase, alongside more expected actives such as fermented niacinamide and hyaluronic acid.

In 2025 the day cream became the debut commercial use of EcoFLEXY, a biodegradable cellulose ingredient made by fermenting sugar. EcoFLEXY is the proprietary ingredient of Cellugy, a separate Danish biotech firm that shares the same Alfa Laval Innovation House address; the two companies collaborated on the launch, which was scaled up and presented at the In-Cosmetics Global exhibition in Amsterdam in April 2025 [8].

Environmental claims sit at the core of the brand rather than at its margins. Bioli says its ingredients and packaging are fully biodegradable, with containers made from fermented microorganisms that break down in home compost within 52 weeks [5]. It avoids petrochemicals, microplastics and glass packaging, and ships orders in a single compostable, FSC-certified paper bag instead of boxes.

The company points to several third-party checks. Its products carry AllergyCertified, a Danish scheme under which each ingredient is assessed by toxicologists and pharmacists, and it cites a top A-rating from the Danish Consumer Council Tænk. Packaging materials are described as OK compost HOME certified, and the brand says its environmental claims are backed by life cycle analysis.

Bioli has drawn Danish press attention, including an interview in ELLE Denmark on using biotechnology to change how skincare is made, and a review in Femina. Beyond national coverage, the Cellugy partnership brought the brand into industry reporting on biofabricated cosmetic ingredients.

The brand is active. Its journal continued publishing into mid-2026, and it sells directly across the European Union as well as through a small set of retail partners in Denmark, Italy, France and the Czech Republic. As an independent company founded in 2021, its documented history is still short, and no ownership changes or acquisitions are on record.